Oct 21, 2019
Neuronetics CEO Chris Thatcher to Ring Nasdaq Closing Bell on October 22 in Honor of National Depression Awareness Month
Oct 20, 2019
LiveWell TMS Brings Breakthrough Transcranial Magnetic Stimulation Depression Treatment to Huntington Area
Oct 03, 2019
Neuronetics® Unveils Promising New Depression Research Data at Psych Congress
Sep 25, 2019
Neuromodulation Devices Global Market - Forecast To 2026
Sep 12, 2019
Former Pittsburgh Steeler Merril Hoge teams up with mental health clinic Transformations
Sep 04, 2019
Neuronetics® Announces Greenbrook® TMS Installation Milestone for NeuroStar® Advanced Therapy System
Aug 27, 2019
neuroCare Centers of America Growth Continues, Strategic Partnership Adds Second Nashville-area Clinic
Aug 19, 2019
Researchers at USU Unveil Neuronetics®-supported Clinical Research for PTSD and Traumatic Brain Injury at the Military Health System Research Symposium
Aug 01, 2019
Neuronetics® Announces First TMS Patient Treated Under New Japan Reimbursement Policy
Jul 29, 2019
Neuronetics® Launches TrakStar® Plus Patient Data Management System to Maximize Physician Time with Patients
Jul 08, 2019
NeuroStar® Patient Outcomes Registry Has Now Surpassed 3,000 Evaluable Patients, Making It The World's Largest in Major Depressive Disorder
Mar 21, 2019
Neuronetics, Inc. Celebrates Dr. Charles Epstein's Contributions to Magnetic Stimulation Research
Jan 07, 2019
Duncan Family Healthcare Brings Breakthrough Transcranial Magnetic Stimulation Treatment to Reno Region
Nov 13, 2018
NeuroStar® Advanced Therapy and Transformations TMS Expanding Partnership to Increase Patient Access to Depression Treatment
Oct 11, 2018
NeuroStar® Advanced Therapy Hits 2 Million Treatments During National Depression Awareness Month
May 14, 2018
Boston TMS Therapy Center Earns NeuroStar® Gold Circle Provider Status
May 05, 2018
NeuroStar® Advanced Therapy Reaches Monumental Milestone of 1.7 Million Treatments in the US
Oct 16, 2017
Neuronetics, Inc. Partners with Teijin Pharma Limited, a Leading Healthcare Company in Japan, to Distribute NeuroStar Advanced Therapy
Oct 11, 2017
NeuroStar® Advanced Therapy Approved as a Life-Changing Depression Treatment to Help Conquer Depression in Japan